Priorities
$hief $omplaint &'()ST *ssociated S"mptoms+ 'ertinent ,egative S*M'1E 3nitial E-am %etailed 5ocused E-am 7oals of Therap" Monitoring
Assessment Findings
%izziness! Spinning or falling sensation %etermine onset and duration. 'rovo#ed b" changing position or turning head. %izziness! nausea! vomiting! ata-ia! and falls . ith or ithout in/ur"0 E-posure to #no n allergen. 2istor" of $V*+T3*. *4$s and correct an" life threats General Appearance: E"es closed! 'ale Neuro: *1&$6! 5ocal deficits! 'upils Eyes: ,"stagmus ith lateral gaze Maintain *4$s and vitals 4'! 2)! ))! E87! Sp&9.
&rigination :;+9::<
'age = of 9
PARAMEDIC
@se the follo ing medication for treatment of nausea and vomiting associated ith vertigoA o Re#lan =: mg 3V over =B9 minutes or =: 9: mg 3M @se the follo ing medication to reduce vertigoA o "al$u% ? mg 3V
Contact Medical Control for the following: 5urther orders ,otif" medical control if e-trap"ramidal side effects develop from the )eglan. These includeA a0 *#athisia b0 Torticollis c0 &pisthotonus d0 &cculog"ric crisis e0 4uccolingual crisis $onsider 4enadr"l 9? mg 3M or 3V to correct e-trap"ramidal side effects
&rigination :;+9::<
'age 9 of 9